165 related articles for article (PubMed ID: 26425473)
1. Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma.
Gupta P; Khurana ML; Khadgawat R; Bal CS; Kumar G; Sharma SC; Tandon N
Indian J Endocrinol Metab; 2015; 19(5):633-8. PubMed ID: 26425473
[TBL] [Abstract][Full Text] [Related]
2. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
4. A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.
Smy L; Kushnir MM; Frank EL
J Mass Spectrom Adv Clin Lab; 2021 Aug; 21():19-26. PubMed ID: 34820673
[TBL] [Abstract][Full Text] [Related]
5. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
[TBL] [Abstract][Full Text] [Related]
6. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
7. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
[TBL] [Abstract][Full Text] [Related]
8. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A; Uccella S; Marchiori D; La Rosa S; Daraspe J; Balmas Bourloud K; Beck Popovic M; Eugster PJ; Grouzmann E; Abid K
Front Endocrinol (Lausanne); 2022; 13():1027856. PubMed ID: 36531507
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
11. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma and Paraganglioma: A Review of Diagnosis, Management and Treatment of Rare Causes of Hypertension.
Cerqueira A; Seco T; Costa A; Tavares M; Cotter J
Cureus; 2020 May; 12(5):e7969. PubMed ID: 32523826
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma.
Lider Burciulescu SM; Randon C; Duprez F; Huvenne W; Creytens D; Claes KBM; de Putter R; T'Sjoen G; Badiu C; Lapauw B
Endocr Oncol; 2023 Jan; 3(1):e220040. PubMed ID: 37434651
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma and paraganglioma syndromes: genetics and management update.
Lefebvre M; Foulkes WD
Curr Oncol; 2014 Feb; 21(1):e8-e17. PubMed ID: 24523625
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.
Jensterle M; Podbregar A; Janež A; Rakusa M; Goricar K; Prokšelj K
Endocrine; 2022 Dec; 78(3):580-586. PubMed ID: 36194345
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the size of pheochromocytoma and the level of metanephrines.
Rezkallah E; Elsaify A; Hanna R; Elsaify W
Endocr Regul; 2023 Jan; 57(1):183-190. PubMed ID: 37715982
[No Abstract] [Full Text] [Related]
17. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma and abdominal paraganglioma.
Renard J; Clerici T; Licker M; Triponez F
J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
[TBL] [Abstract][Full Text] [Related]
19. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
